Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-04

Clinical Trial Update: Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting completion of a study evaluating fludarabine followed by vaccine therapy and white blood cell infusions for unresectable…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludarabine (Fludarabine)

Snippet

Sponsor: Providence Cancer Center, Earle A. Chiles Research Institute | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED